Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s disease
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 52 (5) , 438-445
- https://doi.org/10.1016/s0006-3223(02)01392-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Parkinsonʼs Disease RevisitedJournal of Neuroscience Nursing, 2000
- Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Clozapine for the treatment of psychosis in Parkinson's disease: a reviewActa Neurologica Scandinavica, 1996
- The Neuropsychiatric InventoryNeurology, 1994
- Psychotic complications of long-term levodopa treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1991
- How much of the placebo ‘effect’ is really statistical regression?Statistics in Medicine, 1983
- A DANGER IN MAKING THE DIAGNOSIS OF PARKINSON'S DISEASEThe Lancet, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975
- CLOZAPINE AND AGRANULOCYTOSISThe Lancet, 1975
- ParkinsonismNeurology, 1967